TCIM
TIAA CREF Investment Management’s Protagonist Therapeutics PTGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-76,640
| Closed | -$658K | – | 3109 |
|
|
2018
Q1 | $658K | Buy |
76,640
+44,106
| +136% | +$379K | ﹤0.01% | 2628 |
|
|
2017
Q4 | $677K | Buy |
32,534
+9,026
| +38% | +$188K | ﹤0.01% | 2647 |
|
|
2017
Q3 | $415K | Buy |
23,508
+136
| +0.6% | +$2.4K | ﹤0.01% | 2912 |
|
|
2017
Q2 | $264K | Buy |
23,372
+3,812
| +19% | +$43.1K | ﹤0.01% | 3057 |
|
|
2017
Q1 | $251K | Sell |
19,560
-3,358
| -15% | -$43.1K | ﹤0.01% | 2959 |
|
|
2016
Q4 | $504K | Buy |
22,918
+12,825
| +127% | +$282K | ﹤0.01% | 2847 |
|
|
2016
Q3 | $213 | Buy |
+10,093
| New | +$213 | ﹤0.01% | 3043 |
|